Literature DB >> 6247274

Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component.

Y Hosaka, Y Fukami, Y Yasuda, J A Bonilla.   

Abstract

Complement-dependent antiviral antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component (P815 mastocytoma cells and L929 cells) was studied with antiviral monospecific sera (anti-F and anti-HN sera). Three types of interactions different in terms of susceptibility of complement-dependent antibody-mediated lysis were distinguished: (i) fusion-positive Sendai viruses induced the susceptibility with both anti-F and anti-HN sera; (ii) fusion-negative envelope particles with F protein induced the susceptibility with only anti-F serum; (iii) noninfectious Sendai viruses with F0 protein induced no susceptibility. The lack of complement-dependent antibody-mediated cytolysis susceptibility in case (iii) was found to be due neither to detachment of cell-associated noninfectious virus in the presence of antiserum nor to antibody-mediated particular redistribution of cell surface virus antigens. Differences in virus or envelope component-cell association in these three cases were discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247274      PMCID: PMC550772          DOI: 10.1128/iai.27.2.355-363.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Functional interactions of viral and histocompatibility antigens at tumor cell surfaces.

Authors:  J W Schrader; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Antibody-induced redistribution of measles virus antigens on the cell surface.

Authors:  B S Joseph; M B Oldstone
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

3.  Artificial assembly of envelope particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion factors from envelopes solubilized by Nonidet P40.

Authors:  Y Hosaka; Y K Shimizu
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

4.  Trypsin action on the growth of Sendai virus in tissue culture cells. II. Restoration of the hemolytic activity if L cell-borne Sendai virus by trypsin.

Authors:  M Homma
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

5.  [Cytotoxic reactions in cells infected with Sendai virus].

Authors:  F Kieling; G Bandlow; R Thomssen
Journal:  Arch Gesamte Virusforsch       Date:  1972

6.  Further observations on the inhibitory effect of myxoviruses on a transplantable murine leukemia.

Authors:  M D Eaton; A R Scala
Journal:  Proc Soc Exp Biol Med       Date:  1969-10

7.  Species source of complement in viral-immune and other cytolytic reactions.

Authors:  M D Eaton; A R Scala
Journal:  Proc Soc Exp Biol Med       Date:  1970-02

8.  The morphological and biological effects of various antisera on avian infectious bronchitis virus.

Authors:  D M Berry; J D Almeida
Journal:  J Gen Virol       Date:  1968-07       Impact factor: 3.891

9.  Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.

Authors:  A C Ehrnst
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

10.  Isolation and purification of the envelope proteins of Newcastle disease virus.

Authors:  A Scheid; P W Choppin
Journal:  J Virol       Date:  1973-02       Impact factor: 5.103

View more
  3 in total

1.  Component(s) of Sendai virus that can induce interferon in mouse spleen cells.

Authors:  Y Ito; Y Hosaka
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

2.  Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins.

Authors:  Y Hosaka
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

3.  Immunoelectron microscopic study on interactions of noninfectious sendai virus and murine cells.

Authors:  Y Yasuda; Y Hosaka; Y Fukami; K Fukai
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.